This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Investors Sweep Bill Ackman Into Dust Bin

One school of thought is Herbalife could simply have experienced a "dead cat bounce" and is on its way back lower. The other thought is that investors are brushing off Ackman's claims -- maybe he is becoming a fade.

Ackman also recently became a major shareholder in JC Penny (JCP - Get Report). Like many, when I read that I was enthusiastic to see positive changes in the company. Unfortunately for JCP investors, the stock closed much lower at the end of 2012 than at the end of 2011.

Considering the size of Ackman's position, it's fair to assume shares will fall further if Ackman liquidates his position anytime soon.

By the same note, it's fair to assume that shares in Herbalife will increase if Ackman has covered his position in whole or in part.

Conclusion

I don't believe the 15% rise in price in the last few days is a dead cat bounce, but I also would not chase this one higher. There is no need to chase, and if you are comfortable with options, look at selling puts and or covered calls as a method to enter. By selling high-volatility options, you allow some wiggle room to get in correctly.

I banked some gains near the open on Wednesday, and will use further price softness to initiate increased bullish positions. I expect continued upside moving into the company's analyst conference coming up in about a week.

At the time of publication, the author was long HLF.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
HLF $55.65 0.00%
JCP $8.55 0.00%
AAPL $126.44 0.00%
FB $87.28 0.00%
GOOG $523.40 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs